VascuMind summarizes educational evidence and clinician-discussion topics for families facing vascular dementia, vascular cognitive impairment, or memory changes after stroke. This page is not medical advice and does not recommend treatment.
Vascular cognitive decline can involve factors clinicians already know how to evaluate and manage. The opportunity is not to self-treat — it is to organize the right questions earlier, benchmark cognition, and bring better information to qualified professionals.
Blood pressure, diabetes, cholesterol, smoking, atrial fibrillation, PAD, heart disease, and prior stroke/TIA history are clinician-directed topics worth organizing and discussing.
A baseline can help families and clinicians compare change over time and decide when formal neuropsychological evaluation or additional workup may be appropriate.
Physical activity, rehabilitation, cognitive training, sleep, hearing/vision, mood, and medication review may all matter depending on the person’s clinical context.
Some families may want to learn about trials or investigational approaches for vascular cognitive impairment. VascuMind provides research awareness, not eligibility or treatment promises.
Supplements can be reviewed as general wellness support only. They do not diagnose, treat, cure, or prevent vascular dementia, stroke, MCI, Alzheimer’s disease, or any disease.
Multiple large trials have evaluated EPA/DHA in cardiovascular and healthy-aging contexts. Effects depend on dose, population, baseline risk, medications, and outcome measured.
Research has evaluated dietary nitrates from beetroot for nitric oxide bioavailability, blood pressure, and endothelial-function markers. These are wellness-related markers, not disease-treatment claims.
The VITACOG trial studied high-dose B vitamins in older adults with mild cognitive impairment and elevated homocysteine. Testing, clinical context, and clinician guidance matter; this does not establish a disease-related benefit for any product.
MCI Screen Disclaimer
The MCI Screen referenced by VascuMind is a cognitive screening, benchmarking, and tracking tool sourced from MCI Screen / EMBIC materials. It does not diagnose vascular dementia or any other medical condition and is not a substitute for clinical evaluation. Results should be discussed with a qualified healthcare provider.